Incremental prognostic value of left atrial and biventricular feature tracking in dilated cardiomyopathy: a long-term study

Table 2 Univariable Cox analysis for prediction of MACE in DCM

Variables	HR	95% CI	P Value
Age	1.00	0.99–1.01	0.840
Sex	0.96	0.64–1.44	0.838
BMI	0.93	0.89–0.97	0.001
BSA	0.47	0.21–1.02	0.055
NYHA class III-IV	1.88	1.50–2.35	< 0.001
Family history	1.79	0.88–3.65	0.109
Dyspnea	2.00	1.33–3.00	0.001
Chest pain	0.63	0.31–1.29	0.210
Palpitation	1.18	0.85–1.62	0.320
Syncope	1.42	0.69–2.89	0.338
Hypertension	0.56	0.39–0.82	0.003
Hypercholesterolemia	0.64	0.43–0.95	0.026
Diabetes	1.23	0.80–1.89	0.347
Smoking	1.10	0.78–1.54	0.605
Excess alcohol	1.18	0.83–1.68	0.351
Heart rate	1.00	0.99–1.01	0.450
Systolic BP	0.97	0.96–0.98	< 0.001
Diastolic BP	0.96	0.94–0.97	< 0.001
NT-proBNP	1.47	1.37–1.58	< 0.001
Beta-blockers	0.78	0.57–1.08	0.138
Anti-arrhythmic	2.12	1.47–3.06	< 0.001
Anti-coagulation	1.04	0.76–1.44	0.790
ACEI/ARB	1.36	0.96–1.91	0.083
Diuretics	1.64	0.83–3.21	0.152
LA diameter	1.07	1.05–1.08	< 0.001
LV diameter	1.03	1.01–1.05	0.001
LVEF	0.95	0.93–0.97	< 0.001
LVEDVI	1.01	1.01–1.02	< 0.001
LVESVI	1.01	1.01–1.02	< 0.001
LV mass index	1.00	1.00–1.01	0.346
LGE presence	3.74	2.49–5.62	< 0.001
LGE extent	1.02	1.00–1.04	0.027
LGE pattern	1.15	0.96–1.38	0.120
Mitral regurgitation	2.14	1.78–2.57	< 0.001
Tricuspid regurgitation	1.59	1.31–1.94	< 0.001
LAεs	0.89	0.86–0.92	< 0.001
LAεe	0.69	0.65–0.74	< 0.001
LAεa	0.93	0.90–0.96	< 0.001
LVGLS	1.21	1.16–1.27	< 0.001
LVGCS	1.12	1.08–1.16	< 0.001
LVGRS	0.96	0.94–0.99	0.003
RVGLS	1.11	1.08–1.14	< 0.001

ISSN: 1532-429X